Sysmex Europe’s Post

Reliance on patient insights provides increased value for the development of new treatments. Understanding health-related quality of life (HRQoL) and disease burden from the patient's perspective offers treatment development teams as much knowledge about unmet clinical needs as assessing the efficacy of new treatments. Visit to learn more: https://lnkd.in/gwkaX4fy #PROs #HRQoL #clinicalinsights

In Crohn’s disease (CD), evolving management goals emphasize a treat-to-target approach. The STRIDE II consensus, developed by healthcare providers (HCPs), aims for endoscopic healing and clinical remission. However, survey data reveal that HCPs and patients may differ in perspectives on symptoms like bowel urgency and fatigue. Addressing these patient experiences is essential for comprehensive CD management. HCPs can learn more here: https://e.lilly/3W94Oa0

Reliance on patient insights provides increased value for the development of new treatments. Understanding health-related quality of life (HRQoL) and disease burden from the patient's perspective offers treatment development teams as much knowledge about unmet clinical needs as assessing the efficacy of new treatments. Visit to learn more: https://lnkd.in/gwkaX4fy #patientinsights #PROs #clinicalresearch

Empower your patient care with precision and insight! Introducing Amerimmune's Standard Immunophenotyping Panel (SIP) – your go-to for swift screening of immune disorders and vigilant monitoring of immunodeficiency. 🌐🔬 Plus, gain crucial insights into your patients' risk of serious complications from SARS-CoV-2. Elevate your diagnostic capabilities and enhance patient outcomes with Amerimmune's advanced healthcare solutions. 🛡️💙 #AmerimmuneSIP #HealthcareInnovation #Immunophenotyping

Big news in coronary care! HeartFlow Plaque Analysis will be covered for Medicare patients. This is a significant milestone in expanding access to non-invasive, AI-powered plaque analysis for patients with coronary artery disease. HeartFlow Plaque Analysis helps clinicians uncover the true plaque burden, providing personalized insights to guide patient treatment. Learn more about this exciting update: https://bit.ly/4dOLIv0. #HeartFlow #HeartFlowPlaqueAnalysis #Plaque #Medicare

This Rare Disease Month, take direct action in the battle against myasthenia gravis. Urge your MG patients to join the MGFA Global Patient Registry. Your recommendation can make a real difference. Patient data is crucial for advancing MG research and paving the way toward better treatments and a potential cure. Encourage your patients to sign up at mgregistry.org and contribute to meaningful medical progress. #RareDiseaseMonth #MGFA #MGstrong

🌍 Today, on World Patient Safety Day, the World Orphan Drug Congress joins the global call to prioritise safety in healthcare, particularly for patients facing rare diseases. This year, the focus is on enhancing diagnostic safety to ensure every patient receives timely and accurate diagnoses. Misdiagnosis or delayed diagnosis can greatly impact treatment outcomes for rare disease patients, making this mission even more critical. Let’s come together to: 1️⃣ Empower patients to be proactive in their diagnosis. 2️⃣ Support healthcare professionals in maintaining excellence in diagnostic practices. 3️⃣ Leverage innovation and technology to improve diagnostic accuracy. Together, we can create safer, more reliable healthcare systems 💙. For more details on how to get involved, visit the WHO’s World Patient Safety Day 2024 page. #WorldPatientSafetyDay #PatientSafety #OrphanDrugs #RareDisease #DiagnosticExcellence #WODC #WorldOrphanDrugCongress

Today is World Patient Safety Day🌐, and it serves as an important reminder of the collective responsibility we have across the life sciences industry. Whether you're working in pharma, biotech, healthcare, or research, patient safety must always be at the heart of what we do. In the orphan drug and rare disease space, ensuring accurate diagnoses and safe treatment protocols is particularly crucial. Many patients face long journeys towards diagnosis, making safety in healthcare delivery even more vital. By fostering collaboration, promoting innovation, and encouraging best practices, we can make strides in improving patient outcomes. View the WHO recommended best practices below! #WorldPatientSafetyDay #LifeSciences #PatientFirst #OrphanDrugs #PatientSafety #HealthcareInnovation

Discover the future of healthcare with precision medicine at Granger Pharmacy! 🩺✨ Partnering with physicians, we deliver personalized treatments tailored just for you. Experience reduced side effects, enhanced efficiency, and improved disease management. Visit www.grangerrx.com today to learn more. #PrecisionMedicine #GrangerPharmacy #PersonalizedCare #HealthcareInnovation

Through the MPE Navigator, myeloma and AL amyloidosis patients can search for clinical trials in Europe. You can find trials aligned with your requirements, whether it is a particular hospital or a specific disease stage. Visit the MPE Navigator: https://lnkd.in/dDRHsv2Z #EuropeanMyelomaDay #LearnShareChange #MPENavigator